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Redox Modulation of T-Type Calcium
Channels in Rat Peripheral Nociceptors
Lingle, 1992; Todorovic and Lingle, 1998). While sub-
types of high-voltage activated (HVA) Ca2channels play
important roles in synaptic transmission, the function
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1 Department of Anesthesiology membrane potentials near the resting potential of most
cells, these channels are thought to regulate cellular2 Department of Psychiatry
3 Department of Ophthalmology excitability under physiological and pathological condi-
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Although their unique biophysical properties make T
currents relatively easy to study in vitro, pharmacologi-Summary
cal tools that allow manipulation of their function are
limited. Unlike the family of HVA Ca2 channels, no natu-Although T-type calcium channels were first described
ral toxins or venom components have been identifiedin sensory neurons, their function in sensory pro-
that alter T channels selectively. Thus, despite theircessing remains unclear. In isolated rat sensory neu-
abundance in nociceptive neurons (Cardens et al., 1995),rons, we show that redox agents modulate T currents
the function of T-type Ca2 channels in sensory pro-but not other voltage- and ligand-gated channels
cessing remains unknown. In the present study, we de-thought to mediate pain sensitivity. Similarly, redox
scribe redox modulation of T-type Ca2 currents in ratagents modulate currents through Cav3.2 recombinant
primary sensory neurons and directly examine the ef-channels. When injected into peripheral receptive
fects of redox agents on thermal and mechanical sensa-fields, reducing agents, including the endogenous
tion following injection into the peripheral receptiveamino acid L-cysteine, induce thermal hyperalgesia.
fields of these neurons. We provide evidence that reduc-This hyperalgesia is blocked by the oxidizing agent
ing agents, including dithiothreitol (DTT) and the endog-5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) and the T
enous amino acid L-cysteine, promote cutaneous ther-channel antagonist mibefradil. DTNB alone and in
mal and mechanical hyperalgesia via effects on Tcombination with mibefradil induces thermal analge-
channels. Conversely, the oxidizing agent 5,5-dithio-sia. Likewise, L-cysteine induces mechanical DTNB-
bis-(2-nitrobenzoic acid) (DTNB) and T-type calciumsensitive hyperalgesia in peripheral receptive fields.
channel antagonist mibefradil produce analgesia to cu-These data strongly suggest a role for T channels in
taneous thermal stimuli. The results demonstrate a novelperipheral nociception. Redox sites on T channels in
role for peripheral T-type Ca2 channels in boosting no-peripheral nociceptors could be important targets for
ciceptive signals. In addition, these results suggest aagents that modify pain perception.
potential role for endogenous or exogenous redox
agents in the modulation of pain sensation.Introduction
ResultsT-type (low-voltage activated [LVA]) Ca2 channels were
first described in peripheral sensory neurons of the dor-
In Vitro Studiessal root ganglion (DRG) (Carbone and Lux, 1984), where
The DRG contains cell bodies of primary afferent (sen-these channels are thought to play a crucial role in the
sory) fibers that originate as pain endings in the periph-control of cell excitability (White et al., 1989). Subse-
ery and terminate in the dorsal horn of the spinal cord.quently, T channels have been identified in a variety of
Whole-cell recordings from dissociated DRG neuronsexcitable and nonexcitable cells (Huguenard, 1996; Ertel
of adult rats are used to study peripheral nociceptiveet al., 1997). Recent cloning of 1 subunits of T channels
mechanisms because the small size of peripheral nervehas revealed the existence of at least three subtypes,
endings precludes direct measurement of currents fromnamed G (Cav3.1; Perez-Reyes et al., 1998), H (Cav3.2;
sensory endings. We limited our experiments to smallCribbs et al., 1998), and I (Cav3.3; Lee et al., 1999), that
diameter (27 m) acutely dissociated neurons be-are likely to contribute to the heterogeneity of T-type
cause the majority of these cells are involved in nocicep-Ca2 currents observed in native cells (Herrington and
tive processing (Cardens et al., 1995; Coderre et al.,
1993; Levine et al., 1993; Snider and McMahon, 1998).5 Correspondence: todorovs@msnotes.wustl.edu
In an effort to identify endogenous modulators of ex-6 Address as of September 1, 2001: University of Virginia Health
citability in sensory neurons, we initially examinedSystem, Department of Anesthesiology, P.O. Box 800710, Char-
lottesville, Virginia 22908. whether redox agents alter voltage-gated currents that
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Figure 1. DTT Selectively Modulates T-Type
Ca2 Currents but Not Other Voltage- and Li-
gand-Gated Currents in Acutely Dissociated
DRG Neurons
(A) The traces depict results from an experi-
ment in which a double-pulse protocol was
used to record T-type (LVA) and HVA Ca2
currents in a DRG cell. Note that 0.1 mM DTT
selectively increased the T current about
2-fold, while the HVA current was not af-
fected. The amplitude of T currents was mea-
sured as the difference from the peak of the
inward current to the current remaining at the
end of a 200 ms test step to avoid contamina-
tion by a small residual HVA component. Note
acceleration of current activation and inacti-
vation kinetics during application of DTT.
(B) The trace shows the lack of effect of 1
mM DTT on isolated HVA Ca2 currents (Vh,
60mV; Vt, 0mV). Bars indicate calibration.
(C) The raw traces show the lack of effect of
4 mM DTT upon voltage-gated Na currents
in another DRG cell. These currents were ob-
tained by holding the neuron at 60mV and
stepping to 0mV. Traces in the absence and
presence of DTT are overlaid.
(D) These panels depict a family of outward
potassium currents elicited from a holding
potential of 60mV to test potentials of 0 to
60mV under control conditions (left) and in
the presence of 3 mM DTT (right). Note the
lack of effects on current kinetics and ampli-
tudes.
(E) Small sensory neurons are sensitive to 1
M capsaicin, heat, protons, and 100 M
ATP, which induce inward currents at
60mV. Representative control traces are
shown for each current on the left; horizontal
bars indicate times of application. Baseline
pH was 7.4 in experiments with proton-gated
currents. The bar graph on the right summa-
rizes the lack of significant effect of DTT on
the peak amplitude of these currents (vertical
bars indicate  SEM). For capsaicin-, proton-,
and ATP-gated currents, 1–3 mM DTT was
coapplied with second application of ligand.
In the case of ATP, we waited for 1 min between applications to allow full recovery of responses (Cook and McCleskey, 1997). For heat-gated
currents, we measured control responses first and then incubated approximately 1–2 mM DTT from 3 to 15 min in the bath before subsequent
application of heat. Both direct application of DTT and bath incubation with DTT result in augmentation of T currents in our experiments.
regulate the excitability of nociceptive cells. We found 35mV, the inactivation time constant () was 50  3.7
ms in control and 25.5  1.6 ms in the presence of DTTthat the reducing agent DTT (0.1 and 1 mM), at a test
potential of 35mV, selectively augmented T-type Ca2 (n 	 5, p  0.01). We also examined whether increasing
the temperature of in vitro experiments to 37
C (thecurrents by 128%  16% (n 	 14) and 142%  18%
(n 	 11), respectively, while leaving HVA Ca2 currents normal in vivo temperature) altered responses to reduc-
ing agents, since higher temperatures are likely to in-in the same cells unaffected (n 	 5 for 0.1 mM, and n 	
7 for 1 mM; Figures 1A and 1B). In all, DTT enhanced T crease the amplitude of T currents and accelerate acti-
vation and inactivation kinetics in the absence of redoxcurrents in 34 of 39 cells (86%), and this effect was
completely reversible within 2 min after removal of DTT. modulation. At 37
C, 0.1 mM DTT increased peak T cur-
rents about 2-fold, similar to the effect observed at 22
C.An apparent steady-state effect was observed with up
to 1 min application of DTT (0.1–1 mM), and no change However, changes in current kinetics with DTT were less
apparent at higher temperatures (n	 3; data not shown).in maximal effect was observed with longer applications
up to 5 min (n 	 3; data not shown). The effect of DTT We also examined the effects of DTT upon voltage-
gated K and Na currents in small-size sensory neu-on T currents was accompanied by a change in current
kinetics. Activation times, measured as the 10%–90% rons. Figure 1C illustrates the lack of effect of 4 mM
DTT on inward Na currents in these cells (n 	 7), andrise times of peak currents, were accelerated in the
presence of DTT. At 35mV, the control 10%–90% rise Figure 1D shows the lack of effect of 3 mM DTT on a
family of outward potassium currents (n 	 5).time was 17.2  2.5 ms, and in the presence of DTT it
was 10.1  1.4 ms (mean  SEM, n 	 5, p  0.05). At T channels are heterogeneously expressed in DRG
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cells of different sizes but are uniformly present in small- 0.1 mM DTNB, the recovery half-time was only 30  3 s
diameter acutely dissociated cells of adult rat (Scroggs (p  0.05).
and Fox, 1992). Small DRG cells have electrical proper-
ties of nociceptors and sensitivity to capsaicin (Todoro- Effects of Redox Agents on Recombinant T-Type
vic and Anderson, 1992; Cardens et al., 1995), features Ca2 Channels
that identify these cells as chemical and thermal noci- Molecular studies have shown that Cav3.2 mRNA is the
ceptive sensory neurons (Snider and McMahon, 1998; most abundant isoform present in small DRG cells (Tal-
Reichling and Levine, 2000; Caterina and Julius, 1999). ley et al., 1999). This subtype of T channels also has the
Therefore, we tested the sensitivity of these cells to a most similar pharmacological profile to the native DRG
variety of noxious stimuli, including capsaicin, heat, acid currents (Todorovic et al., 2000). Therefore, we exam-
pH, and ATP. Capsaicin (1 M) evoked inward currents ined the redox sensitivity of Cav3.2 channels expressed
in 9 of 12 small DRG cells (75%) that had T currents in HEK cells as a representative nociceptor T-type cur-
sensitive to DTT, indicating that our in vitro experiments rent. DTT (0.1 and 1 mM) increased peak T currents by
include cells that participate in thermal and chemical an average of 2.5-fold (157%  50% increase for 0.1
nociception. However, up to 3 mM DTT had no effect mM DTT, n 	 5; Figure 2E). Similar to DRG cells, the
on capsaicin-induced currents (1%  4% change, n 	 increased current was accompanied by acceleration of
6; Figure 1E). To test the sensitivity of heat channels to activation and inactivation kinetics (Figure 2E). The ef-
DTT, we applied heated external solution (45
C  2
C) fects of DTT were mimicked by L-cysteine (n 	 2). Also,
to these cells. Nineteen small DRG cells were studied, similar to DRG cells, 1 mM DTNB blocked Cav3.2 cur-
and ten of them (53%) responded with inward currents, rents by 50%  3.4% (n 	 7; Figure 2E), without signifi-
as depicted in Figure 1E. All DRG neurons responded cant effect on current kinetics, while 3 mM DTNB com-
to low pH (pH 5.3, n 	 9), but only 3 of 15 cells (20%) pletely blocked these currents in HEK cells (n 	 6). On
responded to 100 M ATP. Currents elicited by heat, average, the control 10%–90% rise time at a Vt of30mV
low pH, and ATP were not significantly altered by 1–3 was 8 0.9 ms, and the control inactivation was 24.7
mM DTT (Figure 1E). These data strongly suggest that 2 ms. In the presence of DTT, rise time was 4.9  0.7
DTT selectively modulates T-type Ca2 currents in cap- ms (p  0.05), and inactivation  was 15.8  2 ms (n 	
saicin-sensitive sensory neurons but not other voltage- 9, p 0.05). In the presence of 1 mM DTNB, these times
gated currents or channels thought to mediate heat or were 7.7  0.9 ms and 28  5 ms (n 	 6, p  0.05),
chemical sensitivity. respectively. At lower concentrations, DTNB fully re-
If reducing agents enhance currents through T-type versed effects of DTT on current kinetics (n 	 3; data
Ca2 channels, we would expect that oxidizing agents not shown), peak current amplitude, and time course of
should decrease current flow through these channels. recovery (Figure 2F). The average half-time for the fully
Indeed, application of 1 mM DTNB blocked peak T cur- reduced Cav3.2 channel to spontaneously return to
rents by about 50% (46%  2.7%, n 	 9) in all tested baseline levels was 83  12 s in control conditions and
cells (Figure 2B) and, when applied immediately after 43  3 s in the presence of 0.1 mM DTNB (n 	 3, p 
DTT, reversed the effects of DTT on current kinetics 0.05). These results suggest that Cav3.2 T-type channels,(n 	 5; Figure 2A). In contrast to DTT, DTNB did not the predominant isoform in sensory neurons (Talley et
significantly affect the time course of activation or inacti- al., 1999), have sensitivity to redox agents similar to
vation (at 35mV, the 10%–90% rise time was 17  4.5 native DRG cells.
ms, and the inactivation  was 50.7  5.3 ms, n 	 4,
p  0.05). The half-time for spontaneous recovery from
In Vivo StudiesDTNB was 26  2.5 s (n 	 5; Figure 2B). However, if
Because redox agents modulate T currents in isolated10 M DTT was added immediately after DTNB, half
neurons that participate in thermal nociception, we ex-recovery was achieved in only 13  3 s (p  0.05, n 	
amined whether these agents modify in vivo responses3). The inhibition of peak currents by DTNB was selective
to radiant thermal (heat) stimulation (Jevtovic-Todorovicfor T-type Ca2 channels because applications of up to 3
et al., 1998; Hargreaves et al., 1988). In these studies,mM DTNB, which completely blocked T currents (Figure
100 l of test compounds were injected directly into2B), did not alter HVA Ca2 (n 	 6), voltage-gated Na
peripheral receptive fields of sensory neurons in the(n 	 3), or K (n 	 3) currents (data not shown).
hindpaw of adult rats, and the latency to paw withdrawalThe effects of DTT on T currents were mimicked by
in the presence of a radiant heat stimulus was measured.the endogenous reducing agent L-cysteine (Figure 2C).
Injection of the reducing agent L-cysteine produced aL-cysteine augmented T currents with a threshold of 10
dose-dependent exaggerated thermal response (FigureM and maximal effects at about 100 M (130% 
3B). L-cysteine (12 g/100 l) reversibly decreased paw11% increase, n 	 7). Similar to DTT, L-cysteine also
withdrawal latencies (PWLs) by about 40% 10–20 minincreased rates of current activation and inactivation
(p  0.005) following injection. Injection of the same(Figure 2C). At maximal concentrations, L-cysteine and
volume of vehicle (saline) had no effect on PWLs (FigureDTT consistently increased T currents by about 2-fold.
3A). Similar but less potent hyperalgesic responses wereA low concentration of DTNB (0.1 mM) had little effect
observed following injection of DTT. Compared withon T currents when administered alone (3.3%  3.3%
contralateral, noninjected paws in the same animals,block) but completely reversed the effects of both
150 g/100 l DTT decreased PWLs by 25% 10–20L-cysteine and DTT when applied immediately after a
min after injection (p  0.05; Figure 3C). These changesreducing agent (Figure 2D). The half-time of spontane-
in thermal PWLs are of similar magnitude to effectsous oxidation in four DRG cells after exposure to reduc-
ing agent was 76.6  12 s, while, in the presence of observed in animals with neuropathic pain following in-
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Figure 2. Characterization of Redox Modula-
tion of T-Type Ca2 Currents in Rat Sensory
Neurons and Cav3.2 Currents in HEK Cells
(A) Raw traces from an experiment showing
that DTNB blocks T currents in rat DRG cells
without affecting current kinetics but re-
verses DTT-induced kinetic changes of T cur-
rents. Currents at Vt of 55mV and 40mV
are depicted here (Vh,90mV). The 10%–90%
rise time at 40mV for control was 12.8 ms,
9.6 ms in the presence of 0.1 mM DTT, and
13.6 ms in the presence of 1 mM DTNB, which
was applied immediately after DTT. Inactiva-
tion  at 40mV for control was 53.5 ms; for
DTT, it was 35.3 ms; and for DTNB, it was
50 ms.
(B) DTNB (1 mM and 3 mM) induced a fully
reversible blockade of T currents in DRG
cells. Drug applications are denoted by the
horizontal bars.
(C) L-cysteine mimicked the effects of DTT
in sensory neurons. The traces show results
from an experiment in which T currents were
evoked from a Vh of 90mV to Vt 35mV.
L-cysteine (100M) increased the peak T cur-
rent about 2-fold and increased the speed of
current activation and inactivation, as evi-
denced by crossover of traces prior, during,
and after application of L-cysteine. Bars indi-
cate calibration.
(D) This graph displays results from experi-
ments in which 0.1 mM DTNB increased the
rate of recovery from the effects of L-cysteine
on T currents. Bars indicate times of drug
applications.
(E) DTNB (1 mM) blocked about 60% of the
peak current in HEK cells expressing Cav3.2,
without obvious changes in current kinetics.
DTT (1 mM) in another HEK cell increased the peak Cav3.2 current 2.5-fold and accelerated both activation and inactivation of current. Rise
time (10%–90%) was 9.25 and 6 ms; inactivation  was 20.5 and 11.7 ms before and during application of DTT, respectively.
(F) The graph shows the time course from another experiment in Cav3.2-transfected HEK cell, illustrating that DTNB accelerates recovery
from the fully reduced state (half-time for recovery was 40 versus 90 s with and without DTNB, respectively).
jury to sensory nerves (Jevtovic-Todorovic et al., 1998). gesic response to L-cysteine when injected into hind-
paws (Figure 3D; n 	 8). At this dose, MK-801 has beenL-cysteine and DTT injections did not cause animals to
lick or flinch their paws, suggesting that the reducing reported to block hyperalgesia to peripherally applied
glutamate (Zhou et al., 1996).agents do not directly produce pain but rather augment
transmission of thermal nociceptive signals from periph- If the cutaneous thermal hyperalgesia observed fol-
lowing DTT and L-cysteine results from the reducingeral nerve endings.
It has been shown previously that intrathecal adminis- properties of these agents, then oxidizing agents should
antagonize the hyperalgesia. Indeed, coinjection of 4 g/tration of redox agents can influence pain perception,
putatively by interaction with spinal NMDA receptors 100l DTNB completely reversed the effects of L-cyste-
ine (Figure 4C) and DTT (Figure 4D), while having no(NMDAR) (Laughlin et al., 1998). To explore the potential
role of NMDAR in cutaneous thermal hyperalgesia, we effect on thermal PWLs alone (Figure 4B). Moreover, a
higher dose of DTNB (40 g/100 l) prolonged PWLs,injected 25 g/100 l of ketamine, a noncompetitive
NMDAR antagonist, into hindpaws and found that keta- indicating an analgesic effect (Figure 4B). At 10 min
following injection, DTNB increased the latency time bymine neither altered thermal PWLs (n 	 8) nor affected
the thermal hyperalgesia induced by DTT (n 	 8; data 4.3 s (p  0.0005, n 	 12). This analgesic effect was
completely reversed by 1.5 g/100 l DTT, which hadnot shown). Also, intraplantar injections of a competitive
NMDAR antagonist, D-APV (4 g/100 l), did not affect no effect on its own (n 	 6; data not shown). Dimethyl
sulfoxide (DMSO) (1%), the vehicle used to dissolvebaseline thermal nociception (n 	 8) or L-cysteine-
induced thermal hyperalgesia (n 	 6; data not shown). DTNB, had no effect on PWLs (Figure 4A) and did not
interfere with the effects of the reducing agents (n 	 6;In prior studies, ketamine (2.5 g/100 l) and AP-7 (4
g/100 l) injected locally attenuated the development data not shown).
of thermal hyperalgesia and allodynia associated with
subacute joint inflammation (Lawand et al., 1997). Simi- Reducing Agents Modulate Mechanical Nociception
The majority of small-size sensory neurons are polymo-larly, another even more potent and selective noncom-
petitive NMDA antagonist, MK-801 (0.35 g/100 l), did dal nociceptors that respond to a variety of mechanical,
thermal, and chemical stimuli. If T-type channels servenot affect baseline thermal PWLs (n 	 8) or the hyperal-
T-Type Calcium Channels and Peripheral Nociception
79
Figure 3. Reducing Agents Induce Thermal
Hyperalgesia in Adult Rats
(A) Injections of saline, the vehicle for DTT
and L-cysteine, had no effect on PWLs. “B”
indicates baseline PWL obtained 2 days be-
fore study, and “pretreatment” indicates
value just prior to test injection.
(B) L-cysteine induced a dose-dependent de-
crease of thermal PWLs. L-cysteine (4, [open
triangles], 12 [filled triangles], and 120 [open
squares] g/100 l) significantly decreased
PWLs (*, p  0.005) 10 and 20 min postinjec-
tion when compared with noninjected paws.
PWLs return to control values by 60 min fol-
lowing injection.
(C) DTT, at 15 and 150 g/100 l, also pro-
duced a dose-dependent decrease of PWLs;
*, p  0.05, injected versus noninjected paw.
Note that the effects of L-cysteine and DTT
are fully reversible.
(D) MK-801 (0.35 g/100 l) failed to block
the hyperalgesia induced by 12 g/100 l of
L-cysteine. *, p  0.005, injected versus non-
injected paw.
as general amplifiers of peripheral nociception, these to the ventral side of the hindpaw, causes nociceptive
behavior (measured as the number of paw withdrawalschannels would be expected to be involved in pain sen-
sation generated through other modalities. We therefore per ten trials). These withdrawal responses were com-
pared in injected and noninjected paws before (baselinetested the possibility that mechanical sensation could
also be modulated by redox agents injected in peripheral and 0 min), 10, and 60 min following injection of 100 l
of redox agents in hindpaws. Figure 5A indicates thatreceptive fields of sensory neurons. We first determined
the size of von Frey filament (4.93), which, when applied injections of saline or 1% DMSO did not cause any
Figure 4. DTNB Induces Analgesia in Ther-
mal PWL Testing and Blocks Hyperalgesia
Induced by Reducing Agents
(A) DMSO (1%), the vehicle used for DTNB,
has no effect on PWLs when administered
alone. All points are averages of at least eight
animals, and vertical bars indicate  SEM.
(B) The oxidizing agent DTNB induced a brief
dose-dependent analgesia. *, p  0.0005, in-
jected versus noninjected paws, with full re-
covery after 20 min from injection.
(C) At 4 g/100 l, DTNB had no effect on
PWL alone. However, this dose completely
reversed L-cysteine-induced thermal hyper-
algesia.
(D) Similarly, 4 g/100 l DTNB also blocked
the effects of DTT on PWLs. There was no
statistical difference between injected and
noninjected paws in (C) or (D). Dotted lines
in (C) and (D) are taken from Figures 3B and
3C, respectively.
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Figure 5. Redox Agents Modulate Peripheral
Mechanical Nociception
(A) Injections of saline or 1% DMSO did not
change paw withdrawal responses in animals
tested with a 4.93 von Frey filament (n 	 8
for each condition; control [noninjected]
sides are grouped together).
(B) L-cysteine (12 g/100 L) induced an in-
crease in the withdrawal responses (injected
versus noninjected side) 10 min after injec-
tion. Note a full return of the response to
baseline at 60 min. *, p  0.0001; n 	 8 an-
imals.
(C) When DTNB (40 g/100 l) was injected
in peripheral receptive fields, fewer paw with-
drawals were measured to filament stimula-
tion 10 min after injection, indicating an anal-
gesic response. *, p  0.01; n 	 12 animals.
(D) When a lower dose of DTNB (4 g/100
L) was coinjected with L-cysteine (12 g/
100 l), the hyperalgesic response to me-
chanical stimulation typically observed with
L-cysteine was completely blocked.
change in paw withdrawal responses. However, injec- effects at higher doses. However, coinjection of 6 g/
100 l mibefradil into hindpaws with either L-cysteinetion of 12g/100l L-cysteine in saline caused a revers-
ible hyperalgesic response (Figure 5B), increasing the or DTT completely blocked the thermal hyperalgesia
induced by the reducing agents (Figures 6B and 6C; n	withdrawal responses by 2.6-fold after 10 min (p 
0.0001, n	 8 animals). When 40 g/100 l of DTNB was 8 for L-cysteine, and n 	 14 animals for DTT).
These results are consistent with the idea that theinjected (Figure 5C), withdrawal responses after 10 min
indicated an analgesic effect (60% less than control, hyperalgesic responses to reducing agents result from
modulation of T channels in nociceptors. However, wep  0.01, n 	 12 animals). A lower dose of DTNB (4
g/100 l) had little effect on its own but completely were surprised that mibefradil alone had no effect on
thermal PWLs yet blocked the effects of L-cysteine andreversed the hyperalgesic effect of L-cysteine (Figure
5D; n	 8, p 0.05). Similarly, a lower dose of L-cysteine DTT, given that DTNB had analgesic effects at higher
doses and also inhibited DRG T currents. This led uscompletely reversed the analgesic effects of DTNB (n 	
8; data not shown). These data indicate that redox to examine interactions between mibefradil and redox
agents in vitro. Figure 7A shows data from an experimentagents modulate peripheral mechanical nociception as
well as thermal nociception. in which 100 M L-cysteine enhanced DRG T currents
about 2-fold, and 1 M mibefradil abolished the cyste-
ine-enhanced portion of the current (55% block of theMibefradil Overcomes the Effects of Reducing
Agents Both In Vivo and In Vitro total T current). Also, 0.3 M mibefradil alone did not
block baseline T currents but, when coapplied withThe results described above suggest that redox agents
modulate peripheral thermal nociception via effects on L-cysteine, blocked about 66% of L-cysteine-enhanced
and 28% of total T current. This suggests that reducedT-type Ca2 channels in primary sensory neurons. To
test this further, we used mibefradil, a peripherally acting T channels may have increased affinity for mibefradil.
Indeed, we found that L-cysteine shifted mibefradil’santihypertensive drug that has been shown to block
T-type Ca2 currents preferentially over HVA currents in IC50 for block of T currents from 3 M (Todorovic and
Lingle, 1998) to 0.7 M (Figure 7C).vascular smooth muscle (Ertel and Clozel, 1997, Ertel
et al., 1997) and cerebellar Purkinje cells (McDonough We also examined the effect of DTNB on the T channel
blocking actions of mibefradil. Figure 7B shows an ex-and Bean, 1998). In DRG neurons, we previously found
that mibefradil is one of the most potent blockers of T periment in which a subthreshold concentration of
DTNB (0.2 mM) enhanced the block of T currents bycurrents yet described, with an IC50 of 3 M (Todorovic
and Lingle, 1998). In vivo, injection of 6 g/100 l mibe- 1 M mibefradil by about 2-fold. On average, 1 M
mibefradil alone blocked 23.7% 1.5%, while the com-fradil into rat hindpaws had no significant effect on ther-
mal PWLs (n	 12 animals; Figure 6A). We were unable to bination of 1 M mibefradil and 0.2 mM DTNB blocked
49.2%  1.1% of the current (p  0.001, n 	 4). Consis-examine doses of mibefradil above 6 g/100 l because
mibefradil injections caused hyperemia and increases in tent with this, 0.2 mM DTNB shifted the mibefradil IC50
to 1.1 M (Figure 7C).skin temperature, presumably due to local vasodilating
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sensory neurons. The oxidizing agent DTNB, which is
also relatively membrane impermeant (Aizenman et al.,
1989; Tang and Aizenman, 1993), blocks T currents on
its own at higher concentrations and, at lower concen-
trations, reverses the effects and speeds recovery from
the effects of the reducing agents. DTT and L-cysteine
produce prominent changes in T current kinetics, as
evidenced by acceleration of both activation and inacti-
vation. In contrast, DTNB had little effect on current
kinetics. This suggests the existence of putative extra-
cellular redox sites that modulate T channels in rat sensory
neurons. Furthermore, spontaneous recovery from the
oxidizing effect of DTNB (which results in the formation
of relatively stable disulfide bonds or thiobenzoate-pro-
teins) implies the existence of an unknown endogenous
reducing factor that has access to peripheral nocicep-
tive pathways.
Since DTT, DTNB, and L-cysteine are all highly selec-
tive redox agents for thiol groups on proteins, the redox
sites in rat sensory neurons could involve any of the
many L-cysteine residues present in putative extracellu-
lar regions of T channels (Perez-Reyes et al., 1998;
Cribbs et al., 1998). 2 accessory subunits of voltage-
gated Ca2 channels also contain extracellular disulfide
bonds (De Waard et al., 1996) that could be targets for
redox agents. Studies with cloned subunits indicate that
2-1 can increase the expression of Cav3.1 (1G) immu-
noreactivity at the plasma membrane and increase
Cav3.1-mediated currents without affecting biophysical
properties of the currents in COS cells and Xenopus
oocytes (Dolphin et al., 1999). However, no accessory
subunits have been documented to coexpress function-
ally with T channels in DRG cells. Also we have found
that currents mediated by Cav3.2, the most abundant T
channel isoform in DRG cells (Talley et al., 1999), are
modulated by redox agents in HEK-293 cells in the ab-
sence of added accessory subunits. Although these
data strongly suggest the existence of redox sites di-
Figure 6. Mibefradil Blocks the Effects of Reducing Agents In Vivo rectly on T channels, further biophysical and molecular
(A) Mibefradil, at a dose of 6 g/100 l (filled circles), had a small studies will be necessary to determine the exact nature
but nonsignificant effect on thermal PWLs under control conditions of these sites.(open circles) (n 	 12 animals).
(B) Hyperalgesic responses to 12 g/100 l L-cysteine (dashed
trace, see Figure 3B) were completely blocked when 6 g/100 l Selective Redox Modulation of T Currents in Rat
mibefradil was coinjected with L-cysteine. Sensory Neurons
(C) In another experiment in vivo, 6 g/100 l mibefradil abolished We tested the selectivity of the reducing agents by ex-
the hyperalgesic response to 150 g/100 l DTT (dashed trace, see amining other DRG voltage-gated (HVA, Na, K) cur-Figure 3C). No statistically significant differences were observed
rents and found that only T currents were affected. Thus,between injected paws (solid circles) and noninjected paws (n 	 14
it seems unlikely that the in vivo effects of the reducinganimals).
agents result from effects on other voltage-gated con-
ductances. Modulation of other currents by redoxIn vivo, we found that a combination of ineffective
agents has been reported. For example, redox agentsdoses of DTNB and mibefradil induced analgesia, as
modulate L-type Ca2 currents in ferret ventricular myo-indicated by a 2.5 s increase in thermal PWLs, measured
cytes but in the opposite direction from T currents in10 min after injection (Figure 7D; n 	 12, p  0.001).
DRG cells with DTT blocking and DTNB enhancing cur-This analgesic effect of DTNB plus mibefradil in vivo
rents (Campbell et al., 1996). Redox agents are alsomirrors the synergistic blocking effect of the two agents
known to modulate NMDAR (Aizenman et al., 1989; Tangon T currents in vitro.
and Aizenman, 1993). However, in our in vivo experi-
ments, the hyperalgesic effects of DTT and L-cysteineDiscussion
were not blocked by the NMDAR antagonists ketamine,
MK-801, or D-APV but were blocked by the T-type Ca2Mechanisms of T-Type Ca2 Current Modulation
channel antagonist mibefradil. Additionally, D-APV, ke-by Redox Agents
tamine, and MK-801 injected into peripheral receptiveWe provide evidence that the extracellular reducing
agents DTT and L-cysteine augment T currents in rat fields alone in our study had no effect on baseline ther-
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Figure 7. Redox Agents Augment the Effects
of Mibefradil In Vitro and In Vivo
(A) The graph shows the time course of mibe-
fradil’s blocking effect on L-cysteine-modu-
lated current from a DRG cell. The horizontal
solid bar indicates the time of L-cysteine ap-
plication; dotted bars indicate the times of
mibefradil applications. L-cysteine (100 M)
increased the peak T current by about 2-fold.
Mibefradil (1 M) completely blocked the
L-cysteine-potentiated current, and 3 M mi-
befradil blocked the total T current by80%.
Note that 0.3 M mibefradil applied before
and after L-cysteine did not produce any inhi-
bition of peak T current. However, when
coapplied with L-cysteine, 0.3 M mibefradil
blocked about one third of the total current.
(B) DTNB potentiates the blocking effect of
mibefradil. The graph shows the time course
of an experiment in which DTNB alone (dotted
horizontal bar) had little effect on the baseline
T current. Mibefradil (1 M) (solid horizontal
bar) blocked about 23% of the current. When
DTNB (dotted bar) was coapplied with mibe-
fradil, the magnitude of block increased to
about 50%.
(C) DTNB induces a 3-fold shift and L-cyste-
ine induces a 4-fold shift to the left of the
mibefradil concentration-response curve in
acutely dissociated DRG neurons. The dotted
line is a concentration-response curve to mi-
befradil, obtained with identical recording
conditions in these cells with an IC50 of 3 M
and Hill n of 1.28 (Todorovic and Lingle, 1998).
All points are averages of at least four different cells. Solid lines represent best fits of the Hill equation, giving an IC50 of 1.1  0.14 M and
n of 1.04  0.2 in the presence of 200 M DTNB. Mibefradil had an IC50 of 0.7  0.07 M and n of 1.24  0.14 for T current blockade in the
presence of 100 M L-cysteine.
(D) Mibefradil (6 g/100 l), in combination with an ineffective dose of DTNB (4 g/100 l; filled circles), produced an analgesic effect. Thermal
PWLs were significantly prolonged 10 min after injection from 12.1  0.5 s to 14.7  0.8 s (n 	 12 animals, p  0.005).
mal PWLs. Although NMDAR have been suggested to plasticity and responses to noxious peripheral stimuli.
A similar role for T channels in augmenting subthresholdmediate some peripheral nociceptive processes (La-
wand et al., 1997; Jackson et al., 1995; Zhou et al., 1996), dendritic signals has been described in CNS neurons
(Magee and Johnston, 1995; Markram and Sakmann,our results are consistent with studies suggesting that
NMDA receptors do not contribute to nociception at 1994).
peripheral nerve endings under physiological condi-
tions. These receptors may contribute to pathological Putative Endogenous Redox Modulators
in Rat Sensory Neuronspain states associated with peripheral tissue inflamma-
tion (Lawand et al., 1997; Jackson et al., 1995). The present study demonstrates that the endogenous
amino acid L-cysteine acts as a potent redox modulatorWe find that redox agents modulate both thermal and
mechanical peripheral nociception and that DTT is inef- of T channels in DRG neurons. In the plasma of healthy
human subjects, free L-cysteine concentrations are re-fective in modulating capsaicin-gated and heat-gated
currents in sensory neurons even at several-fold higher ported to be as high as 140 M (Suliman et al., 1997).
Because enhancement of T currents in sensory neuronsconcentrations than affecting T currents. This suggests
that reducing agents do not augment thermal nocicep- occurs with L-cysteine concentrations in the range 10–
100M, it appears that L-cysteine could be an importanttion via effects on the family of heat-sensitive ion chan-
nels in sensory neurons (Caterina and Julius, 1999; endogenous modulator of T currents. Although the con-
centrations of amino acids in the extracellular milieuReichling and Levine, 2000).
It is possible that in some pathological conditions of nociceptive endings is unknown, it is possible that
inflammation, burns, tissue hematoma, or trauma resultthere is cross-talk between redox modulation of T chan-
nels and channels that are thought to be peripheral in plasma extravasation and local accumulation of
L-cysteine and other thiol-containing amino acids innociceptive transducers. However, we found no effect
of reducing agents on currents elicited by heat, acidic proximity to putative nociceptive endings. We show here
that direct injection of L-cysteine into peripheral re-solutions, or ATP. Our results suggest that tissue condi-
tions that favor a more reducing extracellular environ- ceptive fields induces hyperalgesia to thermal and me-
chanical stimuli. It is possible that other thiol- containingment enhance T channel function and boost signals
generated from putative nociceptive endings to the spi- compounds like L-homocysteine or glutathione could
also be endogenous redox modulators of T channelsnal cord. Thus, T channels may contribute to neuronal
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were obtained by trituration in Tyrode’s solution at room tempera-and that these agents could work in concert to upregu-
ture. For recordings, cells were plated onto glass coverslip andlate T channel function.
placed in a culture dish that was perfused with external solution.
All data were obtained from small-diameter neurons (21–27 m)
The Effects of Mibefradil on Redox Modulation without visible processes.
of T-Type Ca2 Channels Transfected Cells
HEK cells were stably transfected with human Cav3.2 constructsIn the present study, we show that concentrations of
(cell lines AH-13 or Q31) as described previously (Lee et al., 1999;mibefradil thought to be selective for T currents com-
Todorovic et al., 2000). Cells were typically used 1–3 days afterpletely block L-cysteine and DTT-enhanced T currents.
plating. Because these cells are routinely grown with 10% fetal
The present results also demonstrate that, among the bovine serum (FBS), which may contain endogenous redox agents,
calcium channels in sensory neurons, T channels are we routinely incubated these cells in our external solution for at
selectively and reversibly augmented by reducing agents least 30 min at room temperature before experiments.
Electrophysiological Recordingsand that reducing agents produce hyperalgesia in re-
Recordings were made with standard whole-cell voltage-clampsponse to thermal stimulation. Because the effects both
techniques (Hamill et al., 1981). Electrodes were fabricated fromin vivo and in vitro are reversed by mibefradil, we postu-
microcapillary tubes and fire polished to resistances of 1–4 M.
late that T currents in peripheral nerve terminals modu- Voltage commands and digitization of membrane currents were
late thermal nociceptive transmission. Mibefradil alone done with Clampex 6.0 of the pClamp software package (Axon In-
blocked T currents in isolated neurons but did not alter struments, Foster City, CA) running on an IBM-compatible com-
puter. Neurons were typically held at 90mV and depolarized tobasal pain sensitivity. However, when animals were ren-
35mV every 20 s to evoke inward T currents. Membrane currentsdered hyperalgesic by application of reducing agents,
were recorded with an EPC 7 patch-clamp amplifier (List Instru-mibefradil blocked the effect. This suggests that T cur-
ments). All T currents are measured as peak response relative to
rent blockers may be useful analgesic agents under con- the end of the depolarizing pulse to avoid small contaminating HVA
ditions in which T channel function is upregulated. currents that could be present in some cells. Data were analyzed
When low concentrations of mibefradil are combined using Clampfit (Axon Instruments) and Origin 4.0. Currents were
filtered at 5 kHz. Reported series resistance values were taken di-with subthreshold concentrations of the oxidizing agent
rectly from the reading of the amplifier. Average uncompensatedDTNB, potentiation of block is observed in vitro, and
series resistance for DRG cells was 7.9  4.5 M (mean  SD), andanalgesic effects are produced in vivo. This suggests
the average capacitance was 14  5 pF (mean  SD, n 	 107
that some degree of T channel function is also necessary neurons). For HEK cells, average capacitance (Cm) was 19.5  6 pF
for baseline transmission of thermal nociceptive signals. and average series resistance (Rs) was 4.5  2 M (n 	 14). Series
resistance typically was compensated 50%–70% during experi-
ments. In most experiments, a P/5 protocol was used for onlineT-Type Ca2 Channels May Be Targets for Novel
leakage subtractions.Analgesic Agents
Solutions
Neurotransmitters and neuromodulators released in re- A glass syringe served as a reservoir for a gravity-driven local perfu-
sponse to noxious stimulation are known to alter the sion system that consisted of multiple, independently controlled
influx of Ca2 through ligand- and voltage-gated chan- glass capillary tubes. Switching between solutions was accom-
plished by manually controlled valves, except for applications ofnels in nociceptors (Coderre et al., 1993; Levine et al.,
capsaicin, heat, acid, and ATP, when computer-driven electronic1993). In turn, Ca2 influences the excitability of sensory
valves designed for fast drug applications were used. Most experi-neurons and triggers release of vesicles from neuronal
ments were done at room temperature (20
C–24
C), except when
synaptic terminals (Miller, 1998). This may be particularly the effect of higher temperature on redox modulation of T currents
important in persistent pain models in which central and heat-gated currents was studied. In this case, extracellular solu-
sensitization and synaptic plasticity seem to be contrib- tion was heated in the syringe and perfusion tube by a thermore-
sistive device. The temperature in the bath was measured with auting mechanisms (Coderre et al., 1993; Levine et al.,
microprobe positioned close to the recorded cell. All drugs were1993). Our results indicate that modulation of peripheral
prepared as stock solutions (ATP, MK-801, and ketamine as 10 mM;T-type Ca2 channels influences thermal and mechani-
L-cysteine, DTT, and D-APV as 100 mM stocks in water) and freshly
cal nociceptive inputs. Since many pathological pain diluted to appropriate concentrations at the time of the experiment.
states are associated with exaggerated thermal and me- Final L-cysteine dilutions were done at the time of the experiment
and used within 1 hr because of instability resulting from spontane-chanical nociception (Coderre et al., 1993; Reichling and
ous oxidation in the presence of trace metal ions. Stock solutionsLevine, 2000), peripherally applied T channel antago-
of DTNB (600 mM), capsaicin (10 mM), and mibefradil (100 mM)nists and/or oxidizing agents could represent new
were prepared in DMSO. The maximal concentration of DMSO was
classes of drugs to treat these forms of chronic pain. 0.5% for in vitro experiments. At these concentrations, DMSO had
no effect on either T currents or holding potential (data not shown).
Experimental Procedures Mibefradil (Ro 40-5967) was a kind gift of F. Hoffman-La Roche,
Basel, to Dr. Christopher Lingle. All other chemicals were obtained
Electrophysiological Methods from Sigma (St. Louis, MO) and/or Aldrich Chemicals (Milwaukee, WI).
Acutely Dissociated DRG Neurons The standard external solution used to isolate Ca2 currents con-
Dissociated DRG cells were prepared from adult rats (100–420 gm) tained (in mM) BaCl2, 5–10; tetraethylammonium (TEA) chloride, 160;
and used within 4 hr for whole-cell recordings as described else- N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 10;
where (Todorovic and Lingle, 1998; Todorovic et al., 2000). In brief, with pH adjusted to 7.4 with TEAOH. To isolate T currents, we
eight to ten DRGs from thoracic and lumbar regions were dissected blocked most HVA currents in these cells with intracellular F and
and incubated at 36
C for 60–100 min in Tyrode’s solution containing with application of 5 M nifedipine (L-type HVA channel blocker)
(in mM) NaCl, 140; KCl, 4; MgCl2, 2; glucose, 10; and N-2-hydroxyeth- and 1 M -CgTx-GVIA (-conotoxin-GVIA, N-type HVA blocker) in
ylpiperazine-N-2-ethanesulfonic acid (HEPES), 10; adjusted to pH the external solution (Todorovic and Lingle, 1998). The standard
7.4 with NaOH. This solution was supplemented with 5 mg/ml colla- external solution for recording voltage-gated K and Na currents
genase (Sigma type I) and 5 mg/ml dispase II (Boehringer-Manheim). and capsaicin-, heat-, proton-, and ATP-gated currents contained
The duration of enzymatic treatment did not alter the effects of (in mM) NaCl, 140; KCl, 5; MgCl2, 2; CaCl2, 0.5; glucose 10; and
HEPES, 10; pH 7.4 with NaOH. The standard pipette solution usedredox agents on T-type calcium currents. Single neuronal somata
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to record T and HVA Ca2 currents, capsaicin-, heat-, proton-, and sia Education and Research (FAER)/Abbott Laboratories New Inves-
ATP-gated currents and voltage-gated Na currents contained (in tigator Award (S.M.T.); National Institute for Drug Abuse (NIDA)
mM) Cs-methane sulfonate, 110; phosphocreatine, 14; HEPES, 10; Career Development (KO8) Awards (S.M.T. and V.J.T.); Bantly Foun-
EGTA, 9; Mg-ATP 5; and Tris-GTP, 0.3; pH adjusted to 7.2 with CsOH. dation (C.F.Z.); Grants from the National Institute for Mental Health
For recording voltage-gated potassium currents, KCl replaced Cs- (NIMH) (C.F.Z. and J.W.O.); the National Institute for General Medical
methane sulfonate, and 2 mM QX 314 was added to pipette solution Sciences (NIGMS) (C.F.Z.); National Alliance in Research in Schizo-
to block voltage-gated Na currents. For recording T-type Ca2 phrenia and Depression (NARSAD) Award (S.M.); and the Klin-
currents in isolation, we used the following F-based intracellular genstein Fund (S.M.).
solution (in mM): TEAOH, 135–140; EGTA, 10; HEPES, 40; and MgCl2,
2; titrated to pH 7.15–7.25 with HF. Received December 11, 2000; revised April 25, 2001.
Current Analysis
Concentration-response data were fit to the function PB([MIBE-
ReferencesFRADIL]) 	 PBmax/(1  (IC50/[MIBEFRADIL])n), where PBmax is the
maximal percent block by mibefradil of peak T currents, the IC50 is
Aizenman, E., Lipton, S.A., and Loring, R.H. (1989). Selective modu-the concentration that produces half-maximal block, and n is the
lation of NMDA responses by reduction and oxidation. Neuron 2,apparent Hill coefficient. Fitted values are reported with 95% linear
1257–1263.confidence limits. The time course of T current inactivation was
examined using a single-exponential fit to current decay. Fitting was Campbell, D.L., Stamler, J.S., and Strauss, H.C. (1996). Redox modu-
done either with Origin 4.0 (Microcal Software, Northhampton, MA) lation of L-type calcium channels in ferret ventricular myocytes. J.
or Clampfit 6.0 (Axon Instruments). Gen. Physiol. 108, 277–293.
Carbone, E., and Lux, H.D. (1984). A low-voltage activated, fully
Behavioral Studies
inactivating Ca2 channel in vertebrate sensory neurons. Nature 310,
All experimental protocols were approved by the Washington Uni-
501–502.
versity Animal Studies Committee. The nociceptive response to ther-
Cardens, C.G., Del Mar, L.P., and Scroggs, R.S. (1995). Variation inmal (heat) stimulation was tested in a commercially available paw
serotonergic inhibition of calcium channel currents in four typesthermal stimulation system as described elsewhere (Jevtovic-
of rat sensory neurons differentiated by membrane properties. J.Todorovic et al., 1998). In brief, the device consists of a clear plastic
Neurophysiol. 74, 1870–1879.chamber (10  20  24 cm) that sits on a clear elevated glass floor
and is temperature regulated at 30
C. Adult female Sprague-Dawley Caterina, M.J., and Julius, D. (1999). Sense and specificity: a molecu-
rats were placed in the plastic chamber and given 10–15 min to lar identity for nociceptors. Curr. Opin. Neurobiol. 9, 525–530.
accommodate. A radiant heat source mounted on a portable holder
Coderre, T.J., Katz, J., Vaccarino, A.L., and Melzack, R. (1993). Con-beneath the glass floor was positioned to deliver a thermal stimulus
tribution of central neuroplasticity to pathological pain: review ofto the plantar side of the hindpaw. When an animal withdraws its
clinical and experimental evidence. Pain 52, 259–285.paw, a photocell detects interruption of a light reflection, and an
Cook, S.P., and McCleskey, E.W. (1997). Desensitization, recoveryautomatic timer shuts off. This provides an accurate record of PWL.
and Ca2-dependent modulation of ATP-gated P2X receptors inThe PWL can be measured with this apparatus with a precision of 0.1
nociceptors. Neuropharmacology 36, 1303–1308.s. To prevent injury, the thermal source is automatically discontinued
after 20 s if the rat fails to withdraw its paw. Cribbs, L.L., Lee, J., Yang, J., Satin, J., Zhang, Y., Daud, A., Barcley,
For measurements of mechanical nociception, rats were placed in J., Williamson, M.P., Fox, M., Rees, M., and Perez-Reyes, E. (1998).
a clear plastic, wire mesh-bottomed cage divided into four individual Cloning and characterization of 1H from human heart, a member
compartments, permitting free movement of animals while allowing of the T-type Ca2 channel gene family. Circ. Res. 83, 103–109.
access to the paws. Von Frey Filaments (Stoelting, Wood Dale, IL)
De Waard, M., Gurnett, C.A., and Campbell, K.P. (1996). Structuralwere used to assess the mechanical threshold for paw withdrawal.
and functional diversity of voltage-activated calcium channels. In IonThese filaments are designated by the manufacturer as the log10
Channels, T. Narahashi, ed. (New York: Plenum Press), pp. 41–87.(milligram weight required to cause buckling 10). Ten trials per
filament were used for each test period, and the number of paw Dolphin, A.C., Wyatt, C.N., Richards, J., Beattie, R.E., Craig, P., Lee,
withdrawals was recorded (Sluka and Willis, 1997). We identified J-H., Cribbs, L.L., Volsen, S.G., and Perez-Reyes, E. (1999). The
the filament 4.93 (corresponding to 8.50 gm buckling weight) that effects of 2 and other accessory subunits on expression and
applied to the plantar surface of the foot causes a noxious response properties of the calcium channel 1G. J. Physiol. 519, 35–45.
resulting in an average of three to four paw withdrawals in ten trials. Ertel, S.I., and Clozel, J.-P. (1997). Mibefradil (Ro 40-5967): the first
Baseline was determined first in both paws 1–2 days prior to actual selective T-type Ca2 channel blocker. Exp. Opin. Invest. Drugs 6,
testing and compared to time (just prior to injection, marked as “0” 569–582.
time on our graphs). If these two values differed by more than two
Ertel, S.I., Ertel, E.A., and Clozel, J. (1997). T-type Ca2 channels andwithdrawals, animals were not used for further experiments.
pharmacological blockade: potential pathophysiological relevance.To test the effects of drugs in peripheral receptive fields, we
Cardiovasc. Drugs Ther. 11, 723–739.injected 100 l of test compounds intradermally in the ventral side
of the left hindpaw. The noninjected side (right hindpaw) was used Hamill, O.P., Marty, E., Neher, E., Sakmann, B., and Sigworth, F.J.
as a control in each animal. All solutions were pH balanced to 7.4 (1981). Improved patch-clamp techniques for high-resolution cur-
to avoid skin irritation. No signs of skin inflammation, discoloration, rent recording from cells and cell-free membrane patches. Pfluegers
or irritation were noted at the sites of injection with test compounds. Arch. 381, 85–100.
All doses are expressed in micrograms per 100 L. For animals
Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. (1988).included in this study, baseline values were compared to thermal
A new and sensitive method for measuring thermal nociception inPWLs or withdrawal responses on noninjected and injected paws
cutaneous hyperalgesia. Pain 32, 77–88.at various time points during the testing, as indicated in the figures
Herrington, J., and Lingle, C.J. (1992). Kinetic and pharmacological(posttreatment values). In the data displayed, every point is an aver-
properties of low voltage-activated Ca2 current in rat clonal (GH3)age of at least eight animals, and values represent mean  SEM.
pituitary cells. J. Neurophysiol. 68, 213–232.Statistical analysis was performed using an ANOVA comparing
within-subject variables: paw condition (injected versus nonin- Huguenard, J.R. (1996). Low-threshold calcium currents in central
jected) and test session (prior to drug administration or 10, 20, or nervous system neurons. Annu. Rev. Physiol 58, 329–358.
60 min posttreatment).
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